Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Friedman David Matthew — Benitec Biopharma Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Friedman David Matthew

Friedman David Matthew

Director at Veradermics, Inc · on record since Feb 5, 2026
Director at Avalyn Pharma Inc. · on record since Apr 29, 2026
Director at Benitec Biopharma Inc. · on record since May 28, 2026

Insider trading activity of Friedman David Matthew

Transactions on record: 2; since Feb 5, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing May 28, 2026

Figures computed from official regulatory filings — methodology.

Companies where Friedman David Matthew has traded

Benitec Biopharma Inc.1 tx · May 28, 2026
Veradermics, Inc1 tx · Feb 5, 2026

Track record of Friedman David Matthew

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Friedman David Matthew

Co-insiders of Friedman David Matthew

Averill Madison Master Fund, Ltd.Benitec Biopharma Inc. +1
Averill Master Fund, Ltd.Benitec Biopharma Inc. +1
Cowen AaronBenitec Biopharma Inc. +1
SUVRETTA CAPITAL MANAGEMENT, LLCBenitec Biopharma Inc. +1
Banks Jerel A.Benitec Biopharma Inc.
Baranowski LynAvalyn Pharma Inc.
Boston MeganBenitec Biopharma Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BUCHI J KEVINBenitec Biopharma Inc.

CALIFORNIA CAPITAL EQUITY, LLCBenitec Biopharma Inc.

Carlson Douglas RAvalyn Pharma Inc.

Carrano Dominic GabrielVeradermics, Inc

Carroll JillAvalyn Pharma Inc.

CHILDS JOHN WVeradermics, Inc

Congleton JonAvalyn Pharma Inc.

Coric VladVeradermics, Inc

Durso Timothy AugustVeradermics, Inc

ENRIGHT PATRICK GVeradermics, Inc

FMR LLCAvalyn Pharma Inc.

Francis PeterBenitec Biopharma Inc.

George SimeonAvalyn Pharma Inc.

Golden Adam H.Avalyn Pharma Inc.

Grant-Kels Jane M.Veradermics, Inc

Greco Michael V.Veradermics, Inc

Haviland KateAvalyn Pharma Inc.

Lavelle ErinAvalyn Pharma Inc.

Lazarus HowardAvalyn Pharma Inc.

Longitude 103.8 East, L.P.Veradermics, Inc

Longitude 103.8 East Partners, LLCVeradermics, Inc

Longitude Capital Partners V, LLCVeradermics, Inc

Longitude Venture Partners V, L.P.Veradermics, Inc

Mates SharonBenitec Biopharma Inc.

Mehta KishanBenitec Biopharma Inc.

Mukadam SophieBenitec Biopharma Inc.

Nant Capital, LLCBenitec Biopharma Inc.

Neumann MarkVeradermics, Inc

Novo A/SAvalyn Pharma Inc.

Oliveira Steven MichaelBenitec Biopharma Inc.

Pance KatarinaVeradermics, Inc

Rhodes MelissaAvalyn Pharma Inc.

Seven Fleet Capital Management LPVeradermics, Inc

Smith Edward FBenitec Biopharma Inc.

SOON SHIONG PATRICKBenitec Biopharma Inc.

SR ONE CAPITAL MANAGEMENT, LLCAvalyn Pharma Inc.

Turner Heather DAvalyn Pharma Inc.

Waldman Reid AlexanderVeradermics, Inc

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Avalyn Pharma Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Benitec Biopharma Inc.	May 28, 2026	AwardD	35,000	0.00 USD	$0	SEC
Veradermics, Inc	Feb 5, 2026	AwardD	43,000	0.00 USD	$0	SEC